Padalecki S - Search Results

1

Basic mechanisms responsible for osteolytic and osteoblastic bone metastases.

Guise TA, Mohammad KS, Clines G, Stebbins EG, Wong DH, Higgins LS, Vessella R, Corey E, Padalecki S, Suva L, Chirgwin JM. Guise TA, et al. Among authors: padalecki s. Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6213s-6216s. doi: 10.1158/1078-0432.CCR-06-1007. Clin Cancer Res. 2006. PMID: 17062703 Review.

2

Molecular mechanisms of breast cancer metastases to bone.

Guise TA, Kozlow WM, Heras-Herzig A, Padalecki SS, Yin JJ, Chirgwin JM. Guise TA, et al. Among authors: padalecki ss. Clin Breast Cancer. 2005 Feb;5 Suppl(2):S46-53. doi: 10.3816/cbc.2005.s.004. Clin Breast Cancer. 2005. PMID: 15807924 Review.

3

Actions of bisphosphonates in animal models of breast cancer.

Padalecki SS, Guise TA. Padalecki SS, et al. Breast Cancer Res. 2002;4(1):35-41. doi: 10.1186/bcr415. Epub 2001 Dec 20. Breast Cancer Res. 2002. PMID: 11879558 Free PMC article. Review.

4

Chromosome 18 suppresses prostate cancer metastases.

Padalecki SS, Weldon KS, Reveles XT, Buller CL, Grubbs B, Cui Y, Yin JJ, Hall DC, Hummer BT, Weissman BE, Dallas M, Guise TA, Leach RJ, Johnson-Pais TL. Padalecki SS, et al. Urol Oncol. 2003 Sep-Oct;21(5):366-73. doi: 10.1016/s1078-1439(03)00013-9. Urol Oncol. 2003. PMID: 14670546

5

TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling.

Johnson RW, Nguyen MP, Padalecki SS, Grubbs BG, Merkel AR, Oyajobi BO, Matrisian LM, Mundy GR, Sterling JA. Johnson RW, et al. Among authors: padalecki ss. Cancer Res. 2011 Feb 1;71(3):822-31. doi: 10.1158/0008-5472.CAN-10-2993. Epub 2010 Dec 28. Cancer Res. 2011. PMID: 21189326 Free PMC article.

6

The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells.

Sterling JA, Oyajobi BO, Grubbs B, Padalecki SS, Munoz SA, Gupta A, Story B, Zhao M, Mundy GR. Sterling JA, et al. Among authors: padalecki ss. Cancer Res. 2006 Aug 1;66(15):7548-53. doi: 10.1158/0008-5472.CAN-06-0452. Cancer Res. 2006. PMID: 16885353

7

Temporal changes in the clinical approach to diagnosing prostate cancer.

Hilton WM, Padalecki SS, Ankerst DP, Leach RJ, Thompson IM. Hilton WM, et al. Among authors: padalecki ss. J Natl Cancer Inst Monogr. 2012 Dec;2012(45):162-8. doi: 10.1093/jncimonographs/lgs038. J Natl Cancer Inst Monogr. 2012. PMID: 23271768 Free PMC article.

8

Chromosomal sublocalization of the transcribed human telomere repeat binding factor 2 gene and comparative mapping in the mouse.

Sakaguchi AY, Padalecki SS, Mattern V, Rodriguez A, Leach RJ, McGill JR, Chavez M, Giambernardi TA. Sakaguchi AY, et al. Among authors: padalecki ss. Somat Cell Mol Genet. 1998 May;24(3):157-63. doi: 10.1023/b:scam.0000007118.47691.d7. Somat Cell Mol Genet. 1998. PMID: 10226653

9

Evidence for a novel osteosarcoma tumor-suppressor gene in the chromosome 18 region genetically linked with Paget disease of bone.

Nellissery MJ, Padalecki SS, Brkanac Z, Singer FR, Roodman GD, Unni KK, Leach RJ, Hansen MF. Nellissery MJ, et al. Among authors: padalecki ss. Am J Hum Genet. 1998 Sep;63(3):817-24. doi: 10.1086/302019. Am J Hum Genet. 1998. PMID: 9718349 Free PMC article.

10

Maspin reduces prostate cancer metastasis to bone.

Hall DC, Johnson-Pais TL, Grubbs B, Bernal R, Leach RJ, Padalecki SS. Hall DC, et al. Among authors: padalecki ss. Urol Oncol. 2008 Nov-Dec;26(6):652-8. doi: 10.1016/j.urolonc.2007.07.017. Epub 2008 Jan 15. Urol Oncol. 2008. PMID: 18367129

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page